raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:778

Rett syndrome

Type
Disease
Group
Disorder
Inheritance
X-linked dominant
Age of onset
Infancy
Status
active

A rare severe, X-linked, neurodevelopmental disorder characterized by rapid developmental regression in infancy, partial or complete loss of purposeful hand movements, loss of speech, gait abnormalities, and stereotypic hand movements, commonly associated with deceleration of head growth, severe intellectual disability, seizures, and breathing abnormalities. The disorder has a progressive clinical course and may associate various comorbidities including gastrointestinal diseases, scoliosis, and behavioral disorders.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enRett syndrome
frSyndrome de Rett
deRett-Syndrom
esSíndrome de Rett
itSindrome di Rett
nlSyndroom van Rett
ptSíndrome Rett
plZespół Retta
csRettův syndrom
ukСиндром Ретта
zhRett综合征
trRett sendromu

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM312750Evalidated
ICD-10F84.2Especificvalidated
ICD-11LD90.4Especificvalidated
MONDO0010726Evalidated
MeSHD015518Evalidated
UMLSC0035372Evalidated
GARD5696Evalidated
MedDRA10077709Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (4):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
MECP2Disease-causing germline mutation(s) inAssessedHGNC:6990ENSG00000169057300005Xq28methyl-CpG binding protein 220301670[PMID]
5

Prevalence and incidence

11 records
TypeClassValueAreaQualificationValidationSource
Prevalence at birth1-9 / 100 0005 / 100 000EuropeValue and classNot yet validated12378695[PMID]_21878110[PMID]
Point prevalence1-5 / 10 00010 / 100 000EuropeValue and classValidatedEuropean Medicines Agency 2019[OTHER]
Point prevalence1-9 / 100 000—FranceClass onlyNot yet validated16647997[PMID]_ORPHANET
Point prevalence1-9 / 100 000—WorldwideClass onlyNot yet validatedORPHANET
Point prevalence1-9 / 100 0005 / 100 000SwedenValue and classNot yet validated3571139[PMID]_ORPHANET
Point prevalence1-9 / 100 000—JapanClass onlyNot yet validated2803793[PMID]
Prevalence at birth1-9 / 100 000—United StatesClass onlyNot yet validated2063900[PMID]
Point prevalence1-9 / 100 0001.6 / 100 000United KingdomValue and classValidatedNational Congenital Anomaly and Rare Disease OTHERistration Service 2017[OTHER]_3087206[PMID]
Prevalence at birth1-9 / 100 0003.05 / 100 000AustraliaValue and classNot yet validated21587099[PMID]_ORPHANET
Point prevalence1-9 / 100 000—AustraliaClass onlyNot yet validated21587099[PMID]
Point prevalence1-9 / 100 000—Hong KongClass onlyNot yet validated18174559[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

36 annotations · validated 2024-01-16
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0002793Abnormal pattern of respirationDiagnostic criterion
HP:0000733Abnormal repetitive mannerisms
HP:0001344Absent speech
HP:0002376Developmental regressionDiagnostic criterion
HP:0001288Gait disturbanceDiagnostic criterion
HP:0001263Global developmental delay
HP:0025430High-pitched cry
HP:0007064Progressive language deteriorationDiagnostic criterion
HP:0000253Progressive microcephaly
HP:0012171Stereotypical hand wringingDiagnostic criterion
Frequent (79-30%)
HP:0003808Abnormal muscle toneDiagnostic criterion
HP:0002067Bradykinesia
HP:0003763BruxismDiagnostic criterion
HP:0033850ColdnessDiagnostic criterion
HP:0001332Dystonia
HP:0002353EEG abnormality
HP:0001508Failure to thrive
HP:0001288Gait disturbance
HP:0001510Growth delayDiagnostic criterion
HP:0030217Limb apraxia
HP:0001250Seizure
HP:0003202Skeletal muscle atrophy
Occasional (29-5%)
HP:0500231Abnormal CSF pyruvate family amino acid concentration
HP:0012332Abnormal autonomic nervous system physiologyDiagnostic criterion
HP:0000713Agitation
HP:0001082Cholecystitis
HP:0008947Floppy infant
HP:0001987Hyperammonemia
HP:0002540Inability to walk
HP:0002490Increased CSF lactate
HP:0002151Increased circulating lactate concentration
HP:0003542Increased circulating pyruvate concentration
HP:0031793Increased serum leptin
HP:0002650ScoliosisDiagnostic criterion
HP:0002360Sleep abnormalityDiagnostic criterion
Very rare (<4-1%)
HP:0011451Primary microcephaly

Run the differential on the 10 obligate / very frequent terms

Annotation source: 20301670[PMID]_31645864[PMID]_29445033[PMID]_30648368[PMID]

7

Sources for this card